ATE470665T1 - Cycloalkylaminderivate als inhibitoren der wechselwirkung zwischen mdm2 und p53 - Google Patents

Cycloalkylaminderivate als inhibitoren der wechselwirkung zwischen mdm2 und p53

Info

Publication number
ATE470665T1
ATE470665T1 AT07727060T AT07727060T ATE470665T1 AT E470665 T1 ATE470665 T1 AT E470665T1 AT 07727060 T AT07727060 T AT 07727060T AT 07727060 T AT07727060 T AT 07727060T AT E470665 T1 ATE470665 T1 AT E470665T1
Authority
AT
Austria
Prior art keywords
mdm2
interaction
cycloalkylamin
inhibitors
derivatives
Prior art date
Application number
AT07727060T
Other languages
English (en)
Inventor
Jean Lacrampe
Christophe Meyer
Bruno Schoentjes
Alain Poncelet
Camille Wermuth
Bruno Giethlen
Jean-Marie Contreras
Muriel Joubert
Hijfte Luc Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE470665T1 publication Critical patent/ATE470665T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT07727060T 2006-03-22 2007-03-19 Cycloalkylaminderivate als inhibitoren der wechselwirkung zwischen mdm2 und p53 ATE470665T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06111529 2006-03-22
US78512006P 2006-03-23 2006-03-23
PCT/EP2007/052582 WO2007107545A1 (en) 2006-03-22 2007-03-19 Cyclic-alkylaminederivatives as inhibitors of the interaction between mdm2 and p53

Publications (1)

Publication Number Publication Date
ATE470665T1 true ATE470665T1 (de) 2010-06-15

Family

ID=38110050

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07727060T ATE470665T1 (de) 2006-03-22 2007-03-19 Cycloalkylaminderivate als inhibitoren der wechselwirkung zwischen mdm2 und p53

Country Status (8)

Country Link
US (2) US8088795B2 (de)
EP (1) EP1999126B1 (de)
JP (1) JP5162574B2 (de)
AT (1) ATE470665T1 (de)
AU (1) AU2007228784B2 (de)
CA (1) CA2644649C (de)
DE (1) DE602007007065D1 (de)
WO (1) WO2007107545A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2524922T3 (es) 2005-05-10 2014-12-15 Intermune, Inc. Derivados de piridona para modular el sistema de proteína cinasa activada por estrés
AU2008300483B2 (en) * 2007-09-21 2013-01-10 Janssen Pharmaceutica Nv Inhibitors of the interaction between MDM2 and p53
JP5627574B2 (ja) 2008-06-03 2014-11-19 インターミューン， インコーポレイテッド 炎症性および線維性疾患を治療するための化合物および方法
AU2010210178B2 (en) 2009-02-04 2014-06-05 Janssen Pharmaceutica Nv Indole derivatives as anticancer agents
US8658170B2 (en) 2010-01-06 2014-02-25 Joseph P. Errico Combination therapy with MDM2 and EFGR inhibitors
WO2011098262A2 (en) 2010-02-09 2011-08-18 Universität Bremen P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth
WO2012012653A1 (en) * 2010-07-21 2012-01-26 Errico Joseph P Combination therapy with mdm2 and efgr inhibitors
FR2967072B1 (fr) 2010-11-05 2013-03-29 Univ Dundee Procede pour ameliorer la production de virus et semences vaccinales influenza
US10016414B2 (en) * 2010-11-12 2018-07-10 University Of Massachusetts Modulation of ubiquitination of synaptic proteins for the treatment of neurodegenerative and psychiatric disorders
CN103221094B (zh) * 2010-11-19 2016-04-20 诺华有限公司 Mdm2/4及p53相互作用抑制剂的结晶型
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
US9719970B2 (en) 2012-11-30 2017-08-01 Waters Technologies Corporation Methods and apparatus for the analysis of vitamin D metabolites
BR112015013611A2 (pt) 2012-12-20 2017-11-14 Merck Sharp & Dohme composto, e, composição farmacêutica
AU2014251038A1 (en) 2013-04-08 2015-11-26 Dennis M. Brown Therapeutic benefit of suboptimally administered chemical compounds
UA121309C2 (uk) 2014-02-03 2020-05-12 Вітае Фармасьютікалс, Ллс Дигідропіролопіридинові інгібітори ror-гамма
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.
WO2016020288A1 (en) 2014-08-04 2016-02-11 Nuevolution A/S Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
BR112017007460A2 (pt) 2014-10-14 2017-12-19 Vitae Pharmaceuticals Inc inibidores de di-hidropirrolopiridina de ror-gama
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
US9845308B2 (en) 2014-11-05 2017-12-19 Vitae Pharmaceuticals, Inc. Isoindoline inhibitors of ROR-gamma
US10336703B2 (en) 2015-05-12 2019-07-02 Council Of Scientific And Industrial Research Process for the synthesis of ivacaftor and related compounds
ES2856931T3 (es) 2015-08-05 2021-09-28 Vitae Pharmaceuticals Llc Moduladores de ROR-gamma
CN113521069A (zh) * 2015-10-23 2021-10-22 第一三共株式会社 用于治疗癌症的mdm2抑制剂的给药方案
MX385332B (es) 2015-11-20 2025-03-18 Vitae Pharmaceuticals Llc Moduladores de ror-gamma.
US9630968B1 (en) 2015-12-23 2017-04-25 Arqule, Inc. Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof
TW202220968A (zh) 2016-01-29 2022-06-01 美商維它藥物有限責任公司 ＲＯＲ－γ調節劑
CN109152843A (zh) 2016-05-20 2019-01-04 豪夫迈·罗氏有限公司 Protac抗体缀合物及其使用方法
US9481674B1 (en) 2016-06-10 2016-11-01 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
CA3034010A1 (en) 2016-08-24 2018-03-01 Arqule, Inc. Amino-pyrrolopyrimidinone compounds and methods of use thereof
CN111225914B (zh) 2017-07-24 2022-10-11 生命医药有限责任公司 RORγ的抑制剂
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF ROR GAMMA
JOP20220160A1 (ar) 2019-12-20 2023-01-30 Nuevolution As مركبات فعّالة نحو مستقبلات نووية
EP4076657A1 (de) 2019-12-20 2022-10-26 Nuevolution A/S Gegen nukleäre rezeptoren wirksame verbindungen
MX2022012259A (es) 2020-03-31 2022-12-08 Nuevolution As Compuestos activos frente a receptores nucleares.
MX2022012260A (es) 2020-03-31 2022-11-30 Nuevolution As Compuestos activos frente a receptores nucleares.
WO2023056069A1 (en) 2021-09-30 2023-04-06 Angiex, Inc. Degrader-antibody conjugates and methods of using same
WO2024240858A1 (en) 2023-05-23 2024-11-28 Valerio Therapeutics Protac molecules directed against dna damage repair system and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO863197A0 (en) 1997-08-18 1997-09-11 Fujisawa Pharmaceutical Co., Ltd. Novel derivatives
GB9819860D0 (en) 1998-09-12 1998-11-04 Zeneca Ltd Chemical compounds
US6309492B1 (en) 1998-09-16 2001-10-30 Marc A. Seidner Polymer fill coating for laminate or composite wood products and method of making same
UA71587C2 (uk) * 1998-11-10 2004-12-15 Шерінг Акцієнгезелльшафт Аміди антранілової кислоти та їхнє застосування як лікарських засобів
EE200100302A (et) 1998-12-02 2002-08-15 Pfizer Products Inc. Meetodid ja kompositsioonid p53 perekonna valgu konformatsioonilise stabiilsuse taastamiseks
AU9355101A (en) 2000-09-15 2002-03-26 Anormed Inc Chemokine receptor binding heterocyclic compounds
DK1859798T3 (en) 2001-03-29 2016-03-21 Lilly Co Eli N- (2-arylethyl) -BENZYLAMINER as antagonists of 5-HT6 receptor
EP1403255A4 (de) * 2001-06-12 2005-04-06 Sumitomo Pharma Rho-kinase-inhibitoren
AU2002357728A1 (en) * 2001-11-09 2003-05-19 The Regents Of The University Of California Alpha-helix mimicry by a class of organic molecules
DK1443937T3 (da) 2001-11-13 2008-10-20 Ortho Mcneil Pharm Inc Substituerede 1,4-benzodiazepiner samt deres anvendelse til behnadling af cancer
RU2305095C2 (ru) 2001-12-18 2007-08-27 Ф.Хоффманн-Ля Рош Аг Цис-2,4,5-трифенилимидазолины и фармацевтическая композиция на их основе
GB0215650D0 (en) * 2002-07-05 2002-08-14 Cyclacel Ltd Bisarylsufonamide compounds
GB0419481D0 (en) * 2004-09-02 2004-10-06 Cancer Rec Tech Ltd Isoindolin-1-one derivatives
DK1809622T3 (da) * 2004-09-22 2010-11-08 Janssen Pharmaceutica Nv Inhibitorer af interaktionen mellem MDM2 og P53

Also Published As

Publication number Publication date
US20120071508A1 (en) 2012-03-22
CA2644649C (en) 2014-06-17
US20100168163A1 (en) 2010-07-01
DE602007007065D1 (de) 2010-07-22
JP2009530345A (ja) 2009-08-27
WO2007107545A1 (en) 2007-09-27
AU2007228784A1 (en) 2007-09-27
CA2644649A1 (en) 2007-09-27
US8377961B2 (en) 2013-02-19
EP1999126A1 (de) 2008-12-10
EP1999126B1 (de) 2010-06-09
JP5162574B2 (ja) 2013-03-13
US8088795B2 (en) 2012-01-03
AU2007228784B2 (en) 2012-03-08

Similar Documents

Publication Publication Date Title
ATE470665T1 (de) Cycloalkylaminderivate als inhibitoren der wechselwirkung zwischen mdm2 und p53
ATE547415T1 (de) Inhibitoren der wechselwirkung zwischen mdm2 und p53
SG155941A1 (en) Inhibitors of the interaction between mdm2 and p53
ATE542799T1 (de) Chinolinonderivate als parp und tank-inhibitoren
JO2704B1 (en) Interference inhibition factors between MD2 and B53
IL185275A0 (en) N-sulphonylpyrrole derivatives and pharmaceutical compositions containing the same
TW200610531A (en) Phthalazine derivatives as PARP inhibitors
SG154434A1 (en) Quinazolinone derivatives as parp inhibitors
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
EA201070278A1 (ru) Ингибиторы гамма-секретазы
ATE432272T1 (de) Aminophenylderivate als neue inhibitoren von histondeacetylase
MX2010010406A (es) Tetrahidrofenantridinonas y tetrahidrociclopentaquinolinonas como inhibidores de la polimerizacion de poli(adp-ribosa)polimerasa-1 y tubulina.
EA200700185A1 (ru) Производные хиназолиндиона в качестве ингибиторов parp
EA200970156A1 (ru) Пиридизиноновые производные
ATE547395T1 (de) Aminopropanol-derivate als modulatoren des sphingosin-1-phosphat-rezeptors
BRPI0508966A (pt) composto, composição farmacêutica, e, uso de um composto
EA201200891A1 (ru) Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина
ATE533759T1 (de) Imidazolinon- und hydantoinderivate als neue inhibitoren von histondeacetylase
ATE513818T1 (de) Chinazolinonderivate als tubulinpolymerisationshemmer
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
NO20082185L (no) Heterocykliske CETP-inhibitorer
EA200801145A1 (ru) Спироциклические производные хиназолина в качестве ингибиторов pde7
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
EA200870157A1 (ru) Производные 2-карбамид-4-фенилтиазола, их получение и их применение в терапии

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties